M&A Deal Summary

DSM-Firmenich Acquires Kensey Nash

On May 3, 2012, DSM-Firmenich acquired medical products company Kensey Nash for 360M USD

Acquisition Highlights
  • This is DSM-Firmenich’s 1st transaction in the Medical Products sector.
  • This is DSM-Firmenich’s 10th largest (disclosed) transaction.
  • This is DSM-Firmenich’s 7th transaction in the United States.
  • This is DSM-Firmenich’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2012-05-03
Target Kensey Nash
Sector Medical Products
Buyer(s) DSM-Firmenich
Deal Type Add-on Acquisition
Deal Value 360M USD

Target

Kensey Nash

Exton, Pennsylvania, United States
Kensey Nash is a US based, technology-driven biomedical company, primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. It manufactures and sells medical device parts in cardiology, orthopedic, sports medicine, spinal and general surgery.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

DSM-Firmenich

Kaiseraugst, Switzerland
Category Company
Founded 1902
Sector Chemicals
Employees27,926
Revenue 10.6B EUR (2023)
DESCRIPTION

DSM-Firmenich specializes in development, manufacture and marketing of performance materials, nutritional and pharmaceutical ingredients and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. DSM-Firmenich founded in 1902 and is based in Kaiseraugst, Switzerland.

DEAL STATS #
Overall 13 of 28
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 11 of 19
State (Pennsylvania) 1 of 1
Country (United States) 7 of 11
Year (2012) 2 of 6
Size (of disclosed) 10 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-03-26 Verenium - Food Enzymes Business and Key Technology

United States

Verenium - Food Enzymes Business and Key Technology comprises oilseed processing services and food enzymes and access to biodiversity libraries that Verenium uses proprietary technology.

Buy $37M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-18 Ocean Nutrition Canada

Dartmouth, Nova Scotia, Canada

Ocean Nutrition Canada is a Canada-based supplier of fish-oil derived Omega-3 fatty acids (EPA and DHA) to the dietary supplement and food and beverage markets.

Buy CA$540M
Mergr

Product

Company

Legal